Suppr超能文献

血小板特异性胶原受体糖蛋白 6 基因变异、选定生物标志物与韩国女性复发性妊娠丢失的相关性。

Association between Platelet-Specific Collagen Receptor Glycoprotein 6 Gene Variants, Selected Biomarkers, and Recurrent Pregnancy Loss in Korean Women.

机构信息

Department of Biomedical Science, College of Life Science, CHA University, Seongnam 13488, Korea.

Department of Obstetrics and Gynecology, CHA Bundang Medical Center, School of Medicine, CHA University, Seongnam 13488, Korea.

出版信息

Genes (Basel). 2020 Jul 29;11(8):862. doi: 10.3390/genes11080862.

Abstract

This paper investigates whether glycoprotein 6 () gene polymorphisms are a risk factor for recurrent pregnancy loss (RPL) in Korean women. Genotypes were determined by polymerase chain reaction-restriction fragment length polymorphism and real-time polymerase chain reaction amplification. We identified five polymorphisms in the gene: rs1654410 T>C, rs1671153 T>G, rs1654419 G>A, rs12610286 A>G, and rs1654431 G>A. rs1654410 CC was associated with decreased RPL risk (adjusted odds ratio = 0.292, 95% confidence interval = 0.105-0.815, = 0.019), and recessive genotypes were also significantly associated with decreased RPL risk (adjusted odds ratio = 0.348, 95% confidence interval = 0.128-0.944, = 0.038). rs1654419 GA was associated with decreased RPL risk (adjusted odds ratio = 0.607, 95% confidence interval = 0.375-0.982, = 0.042), and dominant genotypes were significantly associated with decreased RPL risk (adjusted odds ratio = 0.563, 95% confidence interval = 0.358-0.885, = 0.013). Altogether, the genotype frequencies of rs1654410 T>C and rs1654419 G>A were significantly different between RPL patients and control participants. Therefore, although polymorphisms may be useful as biomarkers of RPL, additional studies with heterogeneous cohorts are required to better understand the influence of GP6 and assess its performance as a biomarker.

摘要

本文探讨了糖蛋白 6()基因多态性是否是韩国女性复发性妊娠丢失 (RPL)的风险因素。通过聚合酶链反应-限制性片段长度多态性和实时聚合酶链反应扩增确定基因型。我们在基因中鉴定了五个多态性:rs1654410 T>C、rs1671153 T>G、rs1654419 G>A、rs12610286 A>G 和 rs1654431 G>A。rs1654410 CC 与降低 RPL 风险相关(调整后的优势比=0.292,95%置信区间=0.105-0.815,=0.019),并且隐性基因型也与降低 RPL 风险显著相关(调整后的优势比=0.348,95%置信区间=0.128-0.944,=0.038)。rs1654419 GA 与降低 RPL 风险相关(调整后的优势比=0.607,95%置信区间=0.375-0.982,=0.042),并且显性基因型与降低 RPL 风险显著相关(调整后的优势比=0.563,95%置信区间=0.358-0.885,=0.013)。总的来说,rs1654410 T>C 和 rs1654419 G>A 的基因型频率在 RPL 患者和对照组之间有显著差异。因此,尽管 GP6 多态性可能是 RPL 的有用生物标志物,但需要进行具有异质队列的进一步研究,以更好地了解 GP6 的影响并评估其作为生物标志物的性能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/efb2/7464359/7882edf6f14c/genes-11-00862-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验